MLTX CLASS REMINDER: MoonLake Immunotherapeutics Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 15 Legal Deadline
NEW YORK, Nov. 09, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain